Charles N. York II - Jan 20, 2023 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
COO, CFO and Secretary
Signature
/s/ Charles N. York II
Stock symbol
DAWN
Transactions as of
Jan 20, 2023
Transactions value $
-$227,523
Form type
4
Date filed
1/23/2023, 05:00 PM
Previous filing
Jan 19, 2023
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Sale -$228K -10K -3.59% $22.75 269K Jan 20, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.48 to $23.08 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes 2,313 shares of Common Stock acquired under the Issuer's employee stock purchase plan on November 15, 2021, and May 13, 2022.